Trospium chloride controlled release capsule and preparation method thereof

A technology of trospium chloride and capsules, which is applied in the field of trospium chloride controlled-release capsules and its preparation, can solve the problems of cumbersome patients, difficult promotion of technology, easy forgetting, etc., and achieve guaranteed therapeutic effect, good therapeutic effect and low price Effect
CN102764246AActive Publication Date: 2012-11-07SHOUGUANG FUKANG PHARMA +1

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
SHOUGUANG FUKANG PHARMA
Publication Date
2012-11-07

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The present invention provides a trospium chloride controlled release capsule and a preparation method thereof. A capsule shell is filled with pills; the pills are wrapped with film coatings; a pill cladded with the coating is provided with a hole with a diameter of 0.05 mm; the pills in the capsule shell comprise an active ingredient trospium chloride; controlled release carriers in the pills are sodium carboxymethyl cellulose and natural alginate; a weight ratio of trospium chloride and the controlled release carrier is 1:0.6; a weight ratio of sodium carboxymethyl cellulose sodium and natural alginate is 1:0.8; viscosity of the sodium carboxymethyl cellulose is 3000-5000 centipoise; and viscosity of the natural alginate is 300-500 centipoise. According to the invention, the trospium chloride can be released at a constant speed in 9-12 h, so as to reduce frequency of drug usage.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention relates to medicines, and is a trospium chloride controlled-release capsule and a preparation method thereof. Background technique

[0002] Trospium chloride capsule is a drug for treating overactive bladder. It is a new powerful M receptor blocker with high affinity and specificity for M receptors, and its lipid Low solubility, not through the blood-brain barrier.

[0003] At present, trospium chloride short-acting dosage forms in the domestic and foreign markets are generally trospium chloride tablets 20 mg (such as trade name Sanctura, Germany) and capsules. Because the drug is a symptom-improving drug, it requires long-term concomitant medication for elderly patients. However, these short-acting tablets and capsules on the market at home and abroad are taken 3 times a day, and the number of times of taking is too many to bring loaded down with trivial details to the patient, and it is difficult for the patient to persist in long-ter...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More